CoChat

The Relationship Between Androgens and Days per Month of Period Pain, Pelvic Pain, Headache, and TLR4 Responsiveness of Peripheral Blood Mononuclear Cells in Young Women with Dysmenorrhoea

Open access

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Abstract

Purpose: Women bear a disproportionate burden of persistent pain conditions when compared to men. To determine whether the hormonal environment affects the clinical experience of pain, as measured by the days per month of pelvic pain (DPelvicPM), period pain (DPeriodPM), headache (DHeadachePM) or the in vitro EC 50 for Interleukin-1β (IL-1β) release following TLR4 stimulation with Lipopolysaccharide from Peripheral Blood Mononuclear Cells (PBMCs). Findings were stratified according to use or non-use of the oral contraceptive pill. Patients and Methods: Fifty-six women aged 16– 35 years, with minimal or severe dysmenorrhea, and use or non-use of the OC, were enrolled. Blood was collected on two occasions in a single menstrual cycle: Days 1– 2 and Days 7– 10. Hormonal analysis for testosterone, dihydrotestosterone, dehydroepiandrosterone, Androstenedione, 3α-Androstanediol, 3β-androstanediol, estradiol, estrone, 17α-hydroxyprogesterone, progesterone, cortisol and sex-hormone binding globulin was undertaken using ultra-sensitive Liquid Chromatography Mass–Spectrometry (LC-MS). PBMCs were exposed to lipopolysaccharide (LPS) and the resulting Interleukin-1β output was determined. Results: Non-users of the OC showed a strongly inverse correlation between a reducing free androgen index (FAI) and increasing DPelvicPM (p=0.0032), DPeriodPM (p=0.013), DHeadachePM (p=0.041). Non-users of the OC showed a significant increase in DPelvicPM (p=0.049) on Days 7– 10. Modestly significant associations were found between reduced androgens and potentiated LPS-induced IL-1β (lower EC 50 ). Conclusion: This is the first study to investigate the relationship between the hormonal environment and activation of the immune system in young women with dysmenorrhoea-related pain conditions. Low androgen levels were consistently associated with increased pain. Translational implications for the findings are discussed. Keywords: pain, testosterone, oral contraceptive pill, dysmenorrhoea, pelvic pain, IL-1β

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/jpr.s279253

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Enrolment flow chart for participant recruitment and study inclusion.
Figure 1 Enrolment flow chart for participant recruitment and study inclusion.CC BY-NC · PubMed Central
Figure 2 IL-1β release (Mean ± SEM) following LPS (TLR4) stimulation (12.5pg·mL to 10µg·mL) of PBMC’s obtained from controls: no OC (red circle, solid line), controls: OC (blue square, solid line), dysmenorrhea: no OC (red triangle, dotted line), dysmenorrhea: OC (blue upside down triangle, dotted line), pelvic pain: no OC (red diamond, dashed line), and pelvic pain: OC (blue cross, dashed line). A four-parameter logistic dose–response curve has been fitted to each graph; data obtained from Days 1–2 and Days 7–10 of each individual’s menstrual cycle.
Figure 2 IL-1β release (Mean ± SEM) following LPS (TLR4) stimulation (12.5pg·mL to 10µg·mL) of PBMC’s obtained from controls: no OC (red circle, solid line), controls: OC (blue square, solid line), dysmenorrhea: no OC (red triangle, dotted line), dysmenorrhea: OC (blue upside down triangle, dotted line), pelvic pain: no OC (red diamond, dashed line), and pelvic pain: OC (blue cross, dashed line). A four-parameter logistic dose–response curve has been fitted to each graph; data obtained from Days 1–2 and Days 7–10 of each individual’s menstrual cycle.CC BY-NC · PubMed Central
Figure 3 Comparison between DPelvicPM and levels of Free Androgen Index according to day of testing (Days 1–2 or Days 7–10) and OC use (No OC, OC, or Combined).
Figure 3 Comparison between DPelvicPM and levels of Free Androgen Index according to day of testing (Days 1–2 or Days 7–10) and OC use (No OC, OC, or Combined).CC BY-NC · PubMed Central
Figure 4 Comparison between DPelvicPM and the Estradiol according to day of testing (Days 1–2 or Days 7–10) and OC use (No OC, OC, or Combined).
Figure 4 Comparison between DPelvicPM and the Estradiol according to day of testing (Days 1–2 or Days 7–10) and OC use (No OC, OC, or Combined).CC BY-NC · PubMed Central
Figure 5 Comparison between DPeriodPM and the Free Androgen Index according to day of testing (Days 1–2 or Days 7–10) and OC use (No OC, OC, or Combined).
Figure 5 Comparison between DPeriodPM and the Free Androgen Index according to day of testing (Days 1–2 or Days 7–10) and OC use (No OC, OC, or Combined).CC BY-NC · PubMed Central
Figure 6 Comparison between EC50 and levels of cortisol according to day of testing (Days 1–2 or Days 7–10) and OC use (No OC, OC, or Combined).
Figure 6 Comparison between EC50 and levels of cortisol according to day of testing (Days 1–2 or Days 7–10) and OC use (No OC, OC, or Combined).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 57 references

Research works printed but not linked: 4

  1. Kwok, 2014, PLoS One, 8
  2. Castagnetta, 2003, J Rheumatol, 30, 2597
  3. Smith, 2012, Pain Physician, 15, ES145
  4. Castagnetta, 2020, J Rheumatol, 10

Cited by

See all 21

Metadata

Authors
Evans, S. F., Kwok, Y., Solterbeck, A., Pyragius, C., Hull, M. L., Hutchinson, M. R., & Rolan, P.
Affiliations
  • The University of Adelaide (AU)
  • ARC Centre for Nanoscale BioPhotonics (AU)
Corresponding author
Evans, Susan F
Venue
Journal of Pain Research
Published
2021-03
Volume
Volume 14
Pages
585-599
ISSN
1178-7090 (ISSN-L)
OpenAlex
W3135467103
Cited by
21
References
57
Citations by year
2026: 7 · 2025: 5 · 2024: 3 · 2023: 4 · 2021: 2
FWCI
1.95
Type
journal article
Language
en
Open access
Locations
  • Journal of Pain Research (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
  • Australian and New Zealand College of Anaesthetists
  • Australian Research Council (FT180100565)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
dysmenorrhea, pelvic pain, headache, androgens, free androgen index, oral contraceptives, IL-1β, TLR4, lipopolysaccharide, peripheral blood mononuclear cells, sex hormones, young women, pain conditions, immune activation, menstrual cycle hormones, sex hormone-binding globulin, estradiol

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.